2021 Annual Report Cancer SIG
The SAPC Cancer Special Interest Group was established in late 2018, with the aim of establishing a network of interdisciplinary primary care researchers within SAPC who hold an interest in primary care cancer research, and to provide a supportive environment to share ideas to develop new collaborations and research questions that can be pursued.
The SAPC Cancer SIG has convened a core committee of epidemiologists, clinicians and health economists from six different institutions in England. We have mostly been meeting remotely to date, and exclusively so since the COVID-19 pandemic arrived in the UK.
The COVID-19 pandemic has continued to disrupt the SAPC Cancer SIG’s planned activities. Face-to-face meetings for the core committee have not been possible, and presence at primary care academic meetings has been limited.
A further challenge for the SAPC Cancer SIG has been to define its role and target audience. There are various existing networks and collaborations, including Ca-PRI, the CanTest collaborative, and the National Cancer Research Institute (NCRI) Screening, Prevention and Early Diagnosis group, which include primary care cancer researchers and seek to improve cancer care in UK GP practices. A strength of SAPC is the engagement of a wide range of primary care researchers and support for early career researchers, and the SAPC Cancer SIG could well focus on cross-disciplinary research for early career academics in its future activities.
The SAPC Cancer SIG is developing a member survey to establish the priorities of SAPC members for the Cancer SIGs activities in years to come. Meetings are also planned alongside the Ca-PRI and SAPC meetings in 2022.